SMC accepts lymphoma, lung cancer treatments in latest meeting
The committee recommended four new medicines and rejected two.
8th October 2019
Latest news
Blood, biopsies could be key to lung cancer spread
Around 47,000 people are diagnosed with lung cancer in the UK each year and fewer than one in five survives for five years or more.
7th October 2019
Keytruda to be ‘top drug’ by 2023
The current best selling drug is AbbVie and Eisai’s anti-inflammatory therapy, Himura.
7th October 2019
Sensyne, MHRA form research collaboration
The collaboration will contribute to the development of methods to validate software algorithms used in digital health.
7th October 2019
MiroBio launches with £27m Series A funding
The fundraising was co-led by Oxford Sciences Innovation and Samsara Biocapital
7th October 2019
CMA accuses three drug firms of illegal market sharing
Aspen, Amilco and Tiofarmasigned allegedly signed an illegal agreement that resulted in significant price hikes for fludrocortisone acetate tablets.
4th October 2019
UK to lead 500,000 genome sequencing project
The endeavour is the most ambitious genome sequencing project to date, with £50 million in funding from the UK Government's research and innovation agency.
4th October 2019
Microsoft, Silvercloud to “pioneer” AI in mental health
SilverCloud’s digital mental health platform is used across 75% of NHS mental health services and over 250 organisations globally.
4th October 2019
Psychiatry Consortium launches novel drug project
Applicants can submit project proposals to the consortium from the 7th of October 2019.
4th October 2019
Cognitant, UCB launch interactive healthcare service
The software gives patients access to an interactive explanation of the arthritis disease process.
4th October 2019
Servier acquires Pixuvri from CTI BioPharma
The treatment was approved for use in the European Union in June this year.
3rd October 2019
PIPA releases patient enquiries guidance
The guidance was formed after PIPA found that information provided in response to patient enquiries varied significantly between companies.
3rd October 2019
ABPI details Brexit plans at PIPA conference
ABPI Brexit preparations include ensuring continued UK participation in EU regulatory and medicines safety processes.
3rd October 2019
Gov't moves to curb HRT shortages
Plans will support existing efforts to reduce medicine shortages to protect NHS patients.
3rd October 2019
NICE draft 'no' for Roche's Tecentriq
The committee felt that comparison to existing treatments for the condition was "unreliable and lacked validity".
3rd October 2019
